ReviewJournal of pharmacy & bioallied sciences2025
Genomic Medicine: Applications in Disease Prevention and Treatment.
Review in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Genomas Brasil program: building precision public health within Brazil's Unified Health System.Nature medicine · 2026Article
- Sustained delivery of diagnostic and preventive genomics in primary care: a five-year real-world cohort from a family medicine-embedded multidisciplinary clinic.Frontiers in medicine · 2026Article
- Psychologists' Novel Leadership Roles in Traditionally Medically-Led Organizations: Opportunities for Professional Enrichment and Growth Throughout Career Stages.Journal of clinical psychology in medical settings · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genomic medicine, an emerging field integrating genetic and genomic information into clinical practice, has revolutionized disease prevention, diagnosis, and treatment. Advances in next-generation sequencing, personalized medicine, and pharmacogenomics have enabled precise risk assessment, early disease detection, and tailored therapeutic interventions. The application of genomic medicine spans various medical fields, including oncology, cardiology, neurology, and infectious diseases, facilitating targeted therapies and improving patient outcomes. Additionally, gene-editing technologies such as CRISPR-Cas9 hold promise for correcting genetic disorders at the molecular level. Despite its potential, challenges such as ethical concerns, data privacy, and accessibility remain critical considerations. This review explores the latest advancements, clinical applications, and future prospects of genomic medicine in disease prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.